Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of
bevacizumab/capecitabine/oxaliplatin combination in metastatic or recurrent Korean colorectal
cancer.